Cat. No. |
Product Name |
Information |
PC-35438 |
Ampreloxetine
|
Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively. |
PC-63567 |
AMR-2
|
AMR-2 is a highly potent, orally active, triple reuptake inhibitor of SERT, NET, and DAT with IC50 of 3.0, 3.1, and 8.3 nM, respectively. |
PC-43257 |
Dasotraline hydrochloride
|
Dasotraline (SEP-225289) is a novel triple reuptake inhibitor, antidepressant agent that blocks norepinephrine (NE), dopamine (DA) and serotonin (5-HT) transporters with IC50 values of 4, 6, and 11 nM, respectively. |
PC-63053 |
Atomoxetine hydrochloride
|
Atomoxetine ((R)-Tomoxetine. |
PC-63052 |
Atomoxetine
|
Atomoxetine ((R)-Tomoxetine. |
PC-62373 |
FFN-206 dihydrochloride
|
FFN-206 is an excellent VMAT2 (vesicular monoamine transporter 2) substrate capable of detecting VMAT2 activity in intact cells using fluorescence microscopy, with subcellular localization to VMAT2-expressing acidic compartments without apparent labeling of other organelles. |
PC-61998 |
Edivoxetine hydrochloride
|
Edivoxetine (LY2216684) is a novel potent, selective norepinephrine reuptake inhibitor (NERI) being evaluated as adjunctive treatment for major depressive disorder (MDD).. |
PC-61997 |
Edivoxetine
|
Edivoxetine (LY2216684) is a novel potent, selective norepinephrine reuptake inhibitor (NERI) being evaluated as adjunctive treatment for major depressive disorder (MDD).. |
PC-61884 |
PF-184298
|
PF-184298 is a potent, selective dual serotonin and noradrenaline monoamine reuptake inhibitor (SNRI) with IC50 of 6 nM and 21 nM, respectively. |
PC-70169 |
Amitifadine
|
A triple monoamine reuptake inhibitor, inhibits the reuptake of 5-HT, norepinephrine and dopamine in HEK 293 cells with IC50 of 12, 23 and 96 nM, respectively. |
PC-45481 |
Diclofensine
|
An antidepressant that acts as a triple monoamine reuptake inhibitor. |
PC-45480 |
Diclofensine hydrochloride
|
An antidepressant that acts as a triple monoamine reuptake inhibitor. |